Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...

Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...

In this free webinar, learn how modeling and simulation can help navigate the Animal Rule in drug development. Attendees will gain insight into when the Animal Rule is appropriate to use for drug ...

Join Catherine Tyner, Head of Clinical Strategy, AG Mednet; and Craig McLendon, former Vice President, Adjudication, ...

This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk ...

This session will highlight new research focused on optimizing AAV6 upstream production - an essential step in improving the safety and affordability of gene therapies.

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S.